Nang Kuang Pharmaceutical Co (TPE:1752) Cyclically Adjusted Book per Share: NT$25.92 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1752 Nang Kuang Pharmaceutical Co Ltd TPE:1752
88 GF Score
Price NT$31.35
GF Value NT$46.62
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Nang Kuang Pharmaceutical Co Cyclically Adjusted Book per Share?

Nang Kuang Pharmaceutical Co TPE:1752 -1.10% 88 Cyclically Adjusted Book per Share is NT$25.92 as of Dec. 2025. GuruFocus rates TPE:1752 with a GF Score™ of 88/100 and a GF Value™ of NT$46.62 (Significantly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Nang Kuang Pharmaceutical Co's adjusted book value per share for the three months ended in Dec. 2025 was NT$24.598. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$25.92 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Nang Kuang Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 2.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 3.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 6.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Nang Kuang Pharmaceutical Co was 8.70% per year. The lowest was 3.40% per year. And the median was 7.20% per year.

As of today (2026-07-15), Nang Kuang Pharmaceutical Co's current stock price is NT$31.35. Nang Kuang Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was NT$25.92. Nang Kuang Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 1.21.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Nang Kuang Pharmaceutical Co was 3.38. The lowest was 1.23. And the median was 1.70.


Nang Kuang Pharmaceutical Co  (TPE:1752) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Nang Kuang Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=31.35/25.92
=1.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Nang Kuang Pharmaceutical Co was 3.38. The lowest was 1.23. And the median was 1.70.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Nang Kuang Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Nang Kuang Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Nang Kuang Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nang Kuang Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Nang Kuang Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.32 23.45 24.52 25.41 25.92

Nang Kuang Pharmaceutical Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.41 25.74 25.97 26.08 25.92

TPE:1752 vs ISRG, BDX, MDLN: Cyclically Adjusted Book per Share Comparison

For the Medical Instruments & Supplies subindustry, Nang Kuang Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nang Kuang Pharmaceutical Co Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nang Kuang Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Nang Kuang Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


TPE:1752
88GF Score
Nang Kuang Pharmaceutical Co Ltd TPE:1752
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nang Kuang Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nang Kuang Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=24.598/324.0540*324.0540
=24.598

Current CPI (Dec. 2025) = 324.0540.

Nang Kuang Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201603 20.552 238.132 27.968
201606 19.955 241.018 26.830
201609 20.374 241.428 27.347
201612 21.023 241.432 28.217
201703 21.668 243.801 28.801
201706 20.420 244.955 27.014
201709 20.754 246.819 27.248
201712 21.222 246.524 27.896
201803 21.595 249.554 28.042
201806 20.293 251.989 26.096
201809 20.391 252.439 26.176
201812 20.516 251.233 26.463
201903 20.871 254.202 26.606
201906 20.083 256.143 25.408
201909 20.877 256.759 26.349
201912 21.659 256.974 27.313
202003 22.282 258.115 27.974
202006 21.011 257.797 26.411
202009 21.302 260.280 26.521
202012 21.829 260.474 27.157
202103 22.273 264.877 27.249
202106 21.210 271.696 25.297
202109 21.660 274.310 25.588
202112 22.183 278.802 25.783
202203 22.589 287.504 25.461
202206 21.528 296.311 23.544
202209 22.266 296.808 24.310
202212 23.874 296.797 26.067
202303 24.804 301.836 26.630
202306 23.421 305.109 24.875
202309 23.883 307.789 25.145
202312 23.538 306.746 24.866
202403 22.080 312.332 22.909
202406 22.517 314.175 23.225
202409 23.092 315.301 23.733
202412 23.983 315.605 24.625
202503 23.096 319.799 23.403
202506 23.610 322.561 23.719
202509 24.029 324.800 23.974
202512 24.598 324.054 24.598

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$25.92 mean?
Nang Kuang Pharmaceutical Co (TPE:1752) has a Cyclically Adjusted Book per Share of NT$25.92 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Nang Kuang Pharmaceutical Co and its competitors.
Is Nang Kuang Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Nang Kuang Pharmaceutical Co's current Cyclically Adjusted Book per Share is NT$25.92. Overall, Nang Kuang Pharmaceutical Co has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nang Kuang Pharmaceutical Co's Cyclically Adjusted Book per Share compare to ISRG and BDX?
Nang Kuang Pharmaceutical Co's Cyclically Adjusted Book per Share of NT$25.92 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Nang Kuang Pharmaceutical Co and its competitors. Nang Kuang Pharmaceutical Co's current Cyclically Adjusted Book per Share is NT$25.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nang Kuang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Nang Kuang Pharmaceutical Co (TPE:1752) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$46.62, compared to a current price of NT$31.35 — trading 32.8% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$25.92. Nang Kuang Pharmaceutical Co's overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Nang Kuang Pharmaceutical Co (TPE:1752), the current Cyclically Adjusted Book per Share is NT$25.92 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nang Kuang Pharmaceutical Co (TPE:1752) Overvalued in 2026?

Based on GuruFocus' analysis, Nang Kuang Pharmaceutical Co stock appears to be undervalued. The current stock price of NT$31.35 is trading 32.8% below its estimated GF Value™ of NT$46.62. GuruFocus considers Nang Kuang Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for TPE:1752:

  • Cyclically Adjusted Book per Share: NT$25.92
  • GF Value™: NT$46.62 vs. price of NT$31.35 (32.8% below fair value)
  • GF Score™: 88/100 with 3 warning signs

No single metric tells the full story. See the TPE:1752 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nang Kuang Pharmaceutical Co Business Description

Address Section 8, Civic Boulevard, 5th Floor, No. 205, Nangang District, Taipei, TWN, 115
Nang Kuang Pharmaceutical Co Ltd is a Taiwan-based company, its subsidiaries are engaged in the manufacture, processing, and trading, and import and export of pharmaceuticals and medical devices. Its products are Cardiovascular system medications, Gastrointestinal medications, Nervous system drugs, Nutrition and Metabolism, Hospital infusion solution, blood products, Anticancer immunomodulators, Musculoskeletal system, and Others. Geographically, the company operates in Taiwan, China, Japan, the USA, and Other countries.
88GF Score

Get the complete analysis for TPE:1752

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.35
Price
NT$46.62
GF Value